TABLE 4.
References | Selection | Comparability | Outcome | |||||||
1 | 2 | 3 | 4 | 5A | 5B | 6 | 7 | 8 | Score | |
Cohort | ||||||||||
Holick et al. (10) | * | * | * | * | * | * | * | 8 | ||
Mills et al. (42) | * | * | * | * | * | * | * | * | 8 | |
Dubrow et al. (43) | * | * | * | * | * | * | * | * | * | 7 |
Kuan et al. (9) | * | * | * | * | * | * | * | * | * | 8 |
Case-control | * | * | * | * | * | * | * | |||
Burch et al. (36) | * | * | * | * | * | * | * | * | * | 7 |
Preston-Martin et al. (41) | * | * | * | * | * | * | * | 7 | ||
Boeing et al. (35) | * | * | * | * | * | * | * | 7 | ||
Giles et al. (37) | * | * | * | * | * | * | * | 7 | ||
Blowers et al. (34) | * | * | * | * | * | * | * | 7 | ||
Hu et al. (38) | * | * | * | * | * | * | 6 | |||
Hu et al. (39) | * | * | * | * | * | * | 6 | |||
Xu et al. (40) | * | * | * | * | * | * | * | 7 | ||
Chen et al. (11) | * | * | * | * | * | * | * | 7 | ||
Terry et al. (33) | * | * | * | * | * | * | * | 7 | ||
Cabaniols et al. (32) | * | * | * | * | * | * | * | 7 | ||
Benisi-Kohansal et al. (19) | * | * | * | * | * | * | 6 | |||
Mousavi et al. (18) | * | * | * | * | * | * | 6 | |||
Mousavi et al. (20) | * | * | * | * | * | * | 6 | |||
Malmir et al. (21) | * | * | * | * | * | * | * | 7 | ||
Soltani et al. (24) | * | * | * | * | * | * | 6 | |||
Ebrahimpour-Koujan et al. (22) | * | * | * | * | * | * | * | 7 | ||
Sadeghi et al. (23) | * | * | * | * | * | * | 6 | |||
Ebrahimpour-Koujan et al. (25) | * | * | * | * | * | * | * | 7 | ||
Rigi et al. (26) | * | * | * | * | * | * | 6 |
*For case-control studies, 1, indicates cases independently validated; 2, cases are representative of population; 3, community controls; 4, controls have no history of blood pressure disease; 5A, study controls for age; 5B, study controls for additional factor(s); 6, ascertainment of exposure by blinded interview or record; 7, same method of ascertainment used for cases and controls; and 8, non-response rate the same for cases and controls. For cohort studies, 1, indicates exposed cohort truly representative; 2, non-exposed cohort drawn from the same community; 3, ascertainment of exposure; 4, outcome of interest not present at start; 5A, cohorts comparable on basis of age; 5B, cohorts comparable on other factor(s); 6, quality of outcome assessment; 7, follow-up long enough for outcomes to occur; 8, complete accounting for cohorts.